Skip to main content

Table 3 Perioperative outcomes

From: Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer

Variables

Total patients (n=22)

Peritoneal cancer index (PCI)*

 

 <10

7 (31.8)

 10-19

11 (50.0)

 ≥20

4 (18.2)

 Mean PCI

12.0 ± 7.9 (0-26)

 Median PCI ‡‡

13 (3-17)

Completeness of cytoreduction (CC)

 

 CC-0

22 (100)

 CC-1

0

Total operative time, hour

11.4 ± 2.6 (7.5-16.5)

Operative time for concurrent liver surgery, hour

3.0 ± 2.5 (0.5-9.0)

Estimated blood loss, mL

1418.6 ± 1204.1 (250-5000)

Intraoperative transfusion, mL

475.4 ± 740.4 (0-3030)

Postoperative laboratory findings

 

 CEA , ng/mL

2.6 (0.4-32.9)

 CA 19-9 , U/mL

29.4 (4.1-232)

 Hemoglobin , g/dL

10.6 (7.5-13.7)

 Albumin , g/dL

2.7 (1.4-3.3)

 Total bilirubin , mg/dL

1.3 (0.4-2.4)

 AST , IU/L

170.5 (77-498)

 ALT , IU/L

137 (30-440)

Length of ICU stay, days

3.1 ± 7.9 (0-38)

Length of hospital stay, days

25.6 ± 16.7 (9-71)

Numbers to treat adjuvant chemotherapy*

21 (95.5)

Interval between surgery and adjuvant chemotherapy‡‡, days

40.5 (31-63)

  1. *, n (%); , mean ± standard deviation (range); , median (range); ‡‡, median (quartile); AST aspartate aminotransferase; ALT alanine aminotransferase; ICU intensive care unit